PMID: 9418949Jan 7, 1998Paper

Effect of lipoic acid administration on gentamicin-induced lipid peroxidation in rats

Journal of Applied Toxicology : JAT
P Sandhya, Palaninathan Varalakshmi

Abstract

The intraperitoneal administration of gentamicin (100 mg kg[-1] day[-1]) to rats is associated with an increased production of malondialdehyde (MDA), which is an end product of lipid peroxidation in the kidney. The level of glutathione (GSH) and the activity of three antioxidant systems--superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx)--were also decreased in the kidney. The liver, however, did not show any such alterations. Gentamicin (100 mg kg[-1] day[-1]) plus lipoic acid administration (25 mg kg[-1] day[-1]) by gastric intubation brought about a decrease in the degree of lipid peroxidation. An increase in the GSH level and in the activity of SOD, CAT and GPx was also observed. From these observations it can be concluded that administration of DL-alpha-lipoic acid prevents lipid peroxidation, which may, at least partly, play an important role in the injury cascade of gentamicin-induced nephrotoxicity.

Citations

Apr 20, 2010·Toxicon : Official Journal of the International Society on Toxinology·Valter de Sousa AlegrePaulo Flavio Silveira
Oct 21, 2005·Basic & Clinical Pharmacology & Toxicology·Ilhami CelikH Handan Akbulut
Apr 9, 2010·Basic & Clinical Pharmacology & Toxicology·Ihab T Abdel-Raheem
Jan 6, 2009·Biological & Pharmaceutical Bulletin·Ihab Talat Abdel-RaheemGamal Abdallah Mohamed
Oct 6, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Periandavan KalaiselviPalaninathan Varalakshmi
Sep 11, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yaremi QuirosFrancisco J López-Hernández
Jun 8, 2001·Human & Experimental Toxicology·B H Ali, H M Mousa
May 31, 2003·Human & Experimental Toxicology·A V BalachandarP Varalakshmi
Jul 23, 2014·Asian-Australasian Journal of Animal Sciences·Y LiC Ji
Jun 14, 2003·Renal Failure·Kumaravel Palanichamy MalarkodiPalaninathan Varalakshmi
Jan 5, 2007·Biological & Pharmaceutical Bulletin·Coşkun SilanMüjgan Cengiz
Oct 23, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mark L HudesBruce N Ames
Mar 8, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Viswanathan PragasamPalaninathan Varalakshmi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.